Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Source: CNBC Business
Demand for chefs, personal assistants, butlers, nannies, housekeepers, chauffeurs and estate managers have reached records, according to Morgan & Mallet.
Delta is the first of the U.S. airlines to report second-quarter results.
Barbacoa, brisket and carne asada are taco staples in Texas. But beef prices are continuing to rise due to drought, low herd sizes and concerns about the new world screwworm in the United States. Both
NPR's A Martinez speaks with Mark Zandi, chief economist at Moody's Analytics, who has estimated what the Iran war has cost the average U.S. household so far.
